261 related articles for article (PubMed ID: 28703313)
1. Mesenchymal stem cells: A new platform for targeting suicide genes in cancer.
Moradian Tehrani R; Verdi J; Noureddini M; Salehi R; Salarinia R; Mosalaei M; Simonian M; Alani B; Ghiasi MR; Jaafari MR; Mirzaei HR; Mirzaei H
J Cell Physiol; 2018 May; 233(5):3831-3845. PubMed ID: 28703313
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors.
Amara I; Touati W; Beaune P; de Waziers I
Biochimie; 2014 Oct; 105():4-11. PubMed ID: 24977933
[TBL] [Abstract][Full Text] [Related]
3. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes.
Altanerova U; Jakubechova J; Benejova K; Priscakova P; Pesta M; Pitule P; Topolcan O; Kausitz J; Zduriencikova M; Repiska V; Altaner C
Int J Cancer; 2019 Feb; 144(4):897-908. PubMed ID: 30098225
[TBL] [Abstract][Full Text] [Related]
4. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells: an emerging tool for cancer targeting and therapy.
Fritz V; Jorgensen C
Curr Stem Cell Res Ther; 2008 Jan; 3(1):32-42. PubMed ID: 18220921
[TBL] [Abstract][Full Text] [Related]
6. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas.
Choi SA; Lee JY; Wang KC; Phi JH; Song SH; Song J; Kim SK
Eur J Cancer; 2012 Jan; 48(1):129-37. PubMed ID: 21664124
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice.
Zhang TY; Huang B; Wu HB; Wu JH; Li LM; Li YX; Hu YL; Han M; Shen YQ; Tabata Y; Gao JQ
J Control Release; 2015 Jul; 209():260-71. PubMed ID: 25966361
[TBL] [Abstract][Full Text] [Related]
8. The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase.
Chang DY; Yoo SW; Hong Y; Kim S; Kim SJ; Yoon SH; Cho KG; Paek SH; Lee YD; Kim SS; Suh-Kim H
Int J Cancer; 2010 Oct; 127(8):1975-83. PubMed ID: 20473873
[TBL] [Abstract][Full Text] [Related]
9. Fetal mesenchymal stem cells in cancer therapy.
Bitsika V; Vlahou A; Roubelakis MG
Curr Stem Cell Res Ther; 2013 Mar; 8(2):133-43. PubMed ID: 23176305
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy.
Hu YL; Fu YH; Tabata Y; Gao JQ
J Control Release; 2010 Oct; 147(2):154-62. PubMed ID: 20493219
[TBL] [Abstract][Full Text] [Related]
11. Improved therapeutic potential of MSCs by genetic modification.
Wei W; Huang Y; Li D; Gou HF; Wang W
Gene Ther; 2018 Dec; 25(8):538-547. PubMed ID: 30254305
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cell Exosome-Mediated Prodrug Gene Therapy for Cancer.
Altaner C; Altanerova U
Methods Mol Biol; 2019; 1895():75-85. PubMed ID: 30539530
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cells retrovirally transduced with prodrug-converting genes are suitable vehicles for cancer gene therapy.
Ďuriniková E; Kučerová L; Matúšková M
Acta Virol; 2014; 58(1):1-13. PubMed ID: 24717023
[TBL] [Abstract][Full Text] [Related]
14. A highly efficient non-viral process for programming mesenchymal stem cells for gene directed enzyme prodrug cancer therapy.
Ho YK; Woo JY; Tu GXE; Deng LW; Too HP
Sci Rep; 2020 Aug; 10(1):14257. PubMed ID: 32868813
[TBL] [Abstract][Full Text] [Related]
15. Potential implications of mesenchymal stem cells in cancer therapy.
Dai LJ; Moniri MR; Zeng ZR; Zhou JX; Rayat J; Warnock GL
Cancer Lett; 2011 Jun; 305(1):8-20. PubMed ID: 21396770
[TBL] [Abstract][Full Text] [Related]
16. Engineered mesenchymal stem cells as vectors in a suicide gene therapy against preclinical murine models for solid tumors.
Amara I; Pramil E; Senamaud-Beaufort C; Devillers A; Macedo R; Lescaille G; Seguin J; Tartour E; Lemoine FM; Beaune P; de Waziers I
J Control Release; 2016 Oct; 239():82-91. PubMed ID: 27565211
[TBL] [Abstract][Full Text] [Related]
17. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
[TBL] [Abstract][Full Text] [Related]
18. Stem cell based cancer gene therapy.
Cihova M; Altanerova V; Altaner C
Mol Pharm; 2011 Oct; 8(5):1480-7. PubMed ID: 21755953
[TBL] [Abstract][Full Text] [Related]
19. [Research progress of gene recombinant mesenchymal stem cells as tumor targeting delivery vehicles].
Zhang TY; Hu YL; Liang WQ; Gao JQ
Yao Xue Xue Bao; 2013 Aug; 48(8):1209-20. PubMed ID: 24187826
[TBL] [Abstract][Full Text] [Related]
20. Exosomes of human mesenchymal stem/stromal/medicinal signaling cells.
Altanerova U; Jakubechova J; Repiska V; Altaner C
Neoplasma; 2017; 64(6):809-815. PubMed ID: 28895404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
